Endocrine therapy leads the first- and second-line treatment options for hormone receptor-positive advanced breast cancer—comments on the Monarch plus study
-
Published:2022-01
Issue:
Volume:3
Page:6-6
-
ISSN:2218-6778
-
Container-title:Translational Breast Cancer Research
-
language:
-
Short-container-title:Transl Breast Cancer Res
Publisher
AME Publishing Company